Mehra Anand

Merus N.V. · Director

Mehra Anand is listed in filings as Director at Merus N.V.. This profile follows SEC Form 4 activity through Dec 12, 2025, including purchase activity. Recent filings connect the profile to Merus N.V. (MRUS) and Aclaris Therapeutics, Inc. (ACRS). The current snapshot covers public activity from Nov 20, 2024 to Dec 12, 2025. Reported amounts are shown as $548.8K to $335.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceLast Price
Aclaris Therapeutics, Inc.ACRS$1.5M666.7k sharesBuyNov 19, 2024$2.25$4.58